BACKGROUND AND PURPOSE: High b-value diffusion-weighted imaging (DWI) provides different features not appreciated at lower b-value and have been recently studied in several clinical issues. The purpose of this study was to assess whether DWI at b = 3000 s/mm(2) is more useful in discriminating high-grade and low-grade gliomas than DWI at b = 1000 s/mm(2) at 3T. MATERIALS AND METHODS: DWIs at both b = 1000 and 3000 s/mm(2) were performed at 3T in 62 patients, 49 high-grade gliomas (20 World Health Organization [WHO] grade III and 29 grade IV) and 13 low-grade gliomas (13 grade II). Visual assessments based on 5-point scaled evaluations, receiver operating characteristic (ROC) curve analysis, and quantitative assessment based on DWI signal intensity (SI) ratio (tumor SI/normal SI) and apparent diffusion coefficient (ADC) values were compared between DWIs at b = 1000 and 3000 s/mm(2). RESULTS: By visual assessment, DWI at b = 3000 s/mm(2) showed more conspicuous hyperintensity in high-grade gliomas and hypointensity in low-grade gliomas than DWI at b = 1000 s/mm(2). Sensitivity and specificity at b = 3000 s/mm(2) were higher than at b = 1000 s/mm(2) (83.7%, 84.6% vs 69.4%, 76.9%, respectively). Quantitative assessments showed that mean SI ratio of high-grade gliomas was significantly higher than that of low-grade gliomas at both b-values. The mean ADC value of high-grade gliomas was significantly lower than that of low-grade gliomas at both b-values. The difference between the SI ratios of high-grade and low-grade gliomas was significantly larger at b = 3000 s/mm(2) than at b = 1000 s/mm(2). CONCLUSION: DWI at b = 3000 s/mm(2) is more useful than DWI at b = 1000 s/mm(2) in terms of discriminating high-grade and low-grade gliomas at 3T.
BACKGROUND AND PURPOSE: High b-value diffusion-weighted imaging (DWI) provides different features not appreciated at lower b-value and have been recently studied in several clinical issues. The purpose of this study was to assess whether DWI at b = 3000 s/mm(2) is more useful in discriminating high-grade and low-grade gliomas than DWI at b = 1000 s/mm(2) at 3T. MATERIALS AND METHODS: DWIs at both b = 1000 and 3000 s/mm(2) were performed at 3T in 62 patients, 49 high-grade gliomas (20 World Health Organization [WHO] grade III and 29 grade IV) and 13 low-grade gliomas (13 grade II). Visual assessments based on 5-point scaled evaluations, receiver operating characteristic (ROC) curve analysis, and quantitative assessment based on DWI signal intensity (SI) ratio (tumor SI/normal SI) and apparent diffusion coefficient (ADC) values were compared between DWIs at b = 1000 and 3000 s/mm(2). RESULTS: By visual assessment, DWI at b = 3000 s/mm(2) showed more conspicuous hyperintensity in high-grade gliomas and hypointensity in low-grade gliomas than DWI at b = 1000 s/mm(2). Sensitivity and specificity at b = 3000 s/mm(2) were higher than at b = 1000 s/mm(2) (83.7%, 84.6% vs 69.4%, 76.9%, respectively). Quantitative assessments showed that mean SI ratio of high-grade gliomas was significantly higher than that of low-grade gliomas at both b-values. The mean ADC value of high-grade gliomas was significantly lower than that of low-grade gliomas at both b-values. The difference between the SI ratios of high-grade and low-grade gliomas was significantly larger at b = 3000 s/mm(2) than at b = 1000 s/mm(2). CONCLUSION: DWI at b = 3000 s/mm(2) is more useful than DWI at b = 1000 s/mm(2) in terms of discriminating high-grade and low-grade gliomas at 3T.
Authors: R V Mulkern; H Gudbjartsson; C F Westin; H P Zengingonul; W Gartner; C R Guttmann; R L Robertson; W Kyriakos; R Schwartz; D Holtzman; F A Jolesz; S E Maier Journal: NMR Biomed Date: 1999-02 Impact factor: 4.044
Authors: T W Stadnik; C Chaskis; A Michotte; W M Shabana; K van Rompaey; R Luypaert; L Budinsky; V Jellus; M Osteaux Journal: AJNR Am J Neuroradiol Date: 2001-05 Impact factor: 3.825
Authors: V Tomar; A Yadav; R K S Rathore; S Verma; R Awasthi; V Bharadwaj; B K Ojha; K N Prasad; R K Gupta Journal: AJNR Am J Neuroradiol Date: 2011-09-08 Impact factor: 3.825
Authors: Sarah C Hellewell; Thomas Welton; Alan J Pearce; Jerome J Maller; Stuart M Grieve Journal: Brain Imaging Behav Date: 2021-06 Impact factor: 3.978
Authors: H Hyare; J Thornton; J Stevens; S Mead; P Rudge; J Collinge; T A Yousry; H R Jäger Journal: AJNR Am J Neuroradiol Date: 2009-12-10 Impact factor: 3.825